Atheroregressive Potential of the Treatment with a Chimeric Monoclonal Antibody against Sulfated Glycosaminoglycans on Pre-existing Lesions in Apolipoprotein E-Deficient Mice

The retention of lipoprotein particles in the intima, in particular to glycosaminoglycan side chains of proteoglycans, is a critical step in atherosclerosis initiation. Administration of chP3R99, a chimeric mouse/human monoclonal antibody inducing an anti-idiotypic network response against glycosami...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Front Pharmacol
Autori principali: Brito, Victor, Mellal, Katia, Zoccal, Karina F., Soto, Yosdel, Ménard, Liliane, Sarduy, Roger, Faccioli, Lucia H., Ong, Huy, Vázquez, Ana M., Marleau, Sylvie
Natura: Artigo
Lingua:Inglês
Pubblicazione: Frontiers Media S.A. 2017
Soggetti:
Pharmacology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5672559/
https://ncbi.nlm.nih.gov/pubmed/29163168
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2017.00782
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi